Eisai Co., Ltd. (エーザイ株式会社) (TYO: 4523 ) is one of the leading pharmaceutical global companies, ranking among the top 25. Headquartered in Tokyo, Japan, has some 9000 employees, among them about 1500 in research. Two of the key molecules Eisai developed are donepezil and rabeprazole. The Tokyo Stock Exchange (æ±äº¬è¨¼åˆ¸å–引所 TÅkyÅ ShÅken Torihikijo, abbreviated TSE) is the worlds second-largest stock exchange market. ...
Feeds |
Contact